What Is Lilly Mounjaro
Mounjaro (tirzepatide) is a prescription injectable medication manufactured by Eli Lilly. It is approved by the U.S. Food and Drug Administration for improving blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It is also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
How Mounjaro Works
Mounjaro activates two natural receptors in the body: GLP-1 and GIP. This dual action helps regulate blood sugar, slows gastric emptying, and reduces appetite. These effects can lead to lower blood glucose levels and weight loss. The medication is injected once weekly under the skin of the stomach, thigh, or upper arm.
Key Safety and Usage Information
Common side effects include nausea, diarrhea, decreased appetite, and injection site reactions. Mounjaro carries a boxed warning for thyroid C-cell tumors, including medullary thyroid carcinoma, and is contraindicated in people with a personal or family history of certain thyroid cancers. Serious allergic reactions are possible. Patients should discuss their full medical history and current medications with a healthcare provider before starting treatment. For detailed prescribing information, visit the official Mounjaro site at Mounjaro official site.
